North America is a leading region in the Gastrointestinal Infection Testing market, driven by the high incidence of foodborne illnesses and infections caused by pathogens such as Clostridioides difficile, Salmonella, norovirus, and E. coli. The region benefits from advanced diagnostic infrastructure, widespread adoption of molecular and multiplex PCR-based testing, and the strong presence of...